Literature DB >> 21961635

Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms.

J Armando Villamil1, Carolyn J Henry, Jeffrey N Bryan, Mark Ellersieck, Loren Schultz, Jeff W Tyler, Allen W Hahn.   

Abstract

OBJECTIVE-To identify the most common cutaneous neoplasms in dogs and evaluate breed and age distributions for selected neoplasms. DESIGN-Retrospective epidemiological study. SAMPLE-Records available through the Veterinary Medical Database of dogs examined at veterinary teaching hospitals in North America between 1964 and 2002. PROCEDURES-Information on tumor type and patient breed and age was collected. Incidence and odds ratios with 95% confidence intervals were calculated. RESULTS-Records of 1,139,616 dogs were reviewed. Cutaneous neoplasms were diagnosed in 25,996 of these dogs; records for the remaining 1,113,620 dogs did not indicate that cutaneous neoplasms had been diagnosed, and these dogs were considered controls. The most frequent age range for dogs with cutaneous neoplasms was 10 to 15 years. Lipoma, adenoma, and mast cell tumor were the most common skin tumor types. CONCLUSIONS AND CLINICAL RELEVANCE-Results supported previously reported data regarding cutaneous neoplasia in dogs but provided updated information on the most common skin tumors and on age and breed distributions.

Entities:  

Mesh:

Year:  2011        PMID: 21961635     DOI: 10.2460/javma.239.7.960

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  17 in total

1.  Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade.

Authors:  Hiroyuki Mochizuki; Rachael Thomas; Scott Moroff; Matthew Breen
Journal:  Chromosome Res       Date:  2017-01-05       Impact factor: 5.239

2.  Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization.

Authors:  Kelsey Poorman; Luke Borst; Scott Moroff; Siddharth Roy; Philippe Labelle; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2014-12-16       Impact factor: 5.239

3.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

4.  Prevalence and risk factors for mast cell tumours in dogs in England.

Authors:  Stephanie Jw Shoop; Stephanie Marlow; David B Church; Kate English; Paul D McGreevy; Anneliese J Stell; Peter C Thomson; Dan G O'Neill; David C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2015-01-26

5.  Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head.

Authors:  E P Spugnini; M Pizzuto; M Filipponi; L Romani; B Vincenzi; F Menicagli; A Lanza; R De Girolamo; R Lomonaco; M Fanciulli; G Spriano; A Baldi
Journal:  J Vet Intern Med       Date:  2015-07-20       Impact factor: 3.333

6.  Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.

Authors:  Anna Śmiech; Brygida Ślaska; Wojciech Łopuszyński; Agnieszka Jasik; Diana Bochyńska; Roman Dąbrowski
Journal:  Acta Vet Scand       Date:  2018-11-03       Impact factor: 1.695

7.  Disorder predispositions and protections of Labrador Retrievers in the UK.

Authors:  Camilla Pegram; Charlotte Woolley; Dave C Brodbelt; David B Church; Dan G O'Neill
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

8.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17

Review 9.  Current perspectives on the optimal age to spay/castrate dogs and cats.

Authors:  Lisa M Howe
Journal:  Vet Med (Auckl)       Date:  2015-05-08

10.  Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.

Authors:  William P D Hendricks; Victoria Zismann; Karthigayini Sivaprakasam; Christophe Legendre; Kelsey Poorman; Waibhav Tembe; Nieves Perdigones; Jeffrey Kiefer; Winnie Liang; Valerie DeLuca; Mitchell Stark; Alison Ruhe; Roe Froman; Nicholas S Duesbery; Megan Washington; Jessica Aldrich; Mark W Neff; Matthew J Huentelman; Nicholas Hayward; Kevin Brown; Douglas Thamm; Gerald Post; Chand Khanna; Barbara Davis; Matthew Breen; Alexander Sekulic; Jeffrey M Trent
Journal:  PLoS Genet       Date:  2018-09-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.